Analysis of Patients With Monocytic and Monocytic‐Like Acute Myeloid Leukemia, Including AML ‐ M4 and AML ‐ M5 , Treated With Venetoclax Plus Azacitidine

American Journal of Hematology 2026 Open access

Read full text
Authors: Marina Y. Konopleva, Courtney D. DiNardo, Yan Sun, Paul Jung, Sanam Loghavi, Jalaja Potluri, Monique Dail, Brenda Chyla, D. Pollyea
DOI: 10.1002/ajh.70161
Cited by: 3
References: 13

Abstract

and AML-M5, Treated With Myeloid Leukemia, Including AML-M4 and AML-M5, Treated With Venetoclax Plus Azacitidine Venetoclax Plus Azacitidine

Fields of Study & Subjects

Acute Myeloid Leukemia Research Protein Degradation and Inhibitors Myeloproliferative Neoplasms: Diagnosis and Treatment

Publication details

Journal / source
American Journal of Hematology
Publisher
Wiley
Volume
101
Issue
3
Pages
577–580
Publication date
5 January 2026
Language
EN